Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-036826
Filing Date
2025-03-11
Accepted
2025-03-11 07:24:41
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B3 qttb_prosuppno8_2025.htm 424B3 3248336
2 GRAPHIC img240410186_0.jpg GRAPHIC 3005
3 GRAPHIC img240410186_1.jpg GRAPHIC 444901
4 GRAPHIC img240410186_2.jpg GRAPHIC 610899
5 GRAPHIC img240410186_3.jpg GRAPHIC 191443
6 GRAPHIC img240410186_4.jpg GRAPHIC 657389
7 GRAPHIC img240410186_5.jpg GRAPHIC 215165
8 GRAPHIC img240410186_6.jpg GRAPHIC 165877
9 GRAPHIC img240410186_7.jpg GRAPHIC 258277
10 GRAPHIC img240410186_8.jpg GRAPHIC 78456
11 GRAPHIC img240410186_9.jpg GRAPHIC 63659
  Complete submission text file 0000950170-25-036826.txt   6846291
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278829 | Film No.: 25725852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)